We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




X-Ray Crystallography Reveals Structure of the Arenavirus Binding Complex

By LabMedica International staff writers
Posted on 11 May 2016
Print article
Image: The structure gives scientists a new view of Lymphocytic choriomeningitis mammarenavirus (LCMV), a close relative of the Lassa fever virus (Photo courtesy of the Ollmann Saphire Laboratory, The Scripps Research Institute).
Image: The structure gives scientists a new view of Lymphocytic choriomeningitis mammarenavirus (LCMV), a close relative of the Lassa fever virus (Photo courtesy of the Ollmann Saphire Laboratory, The Scripps Research Institute).
A team of molecular virologists has established the three-dimensional structure of the intensely studied research tool, Lymphocytic choriomeningitis mammarenavirus (LCMV).

LCMV and the closely related, but much deadlier Lassa fever virus are arenaviruses, which exist worldwide and cause hemorrhagic fevers and neurological disease. These viruses are characterized by a single glycoprotein expressed on the viral surface that mediates entry into target cells. This glycoprotein, termed GPC, contains a membrane-associated signal peptide, a receptor-binding subunit termed GP1, and a fusion-mediating subunit termed GP2. Although GPC is a critical target of antibodies and vaccines, the structure of the metastable GP1-GP2 prefusion complex has remained undetermined for all arenaviruses.

When LCMV attacks a cell, attachment of the virus to host receptors through its surface glycoproteins initiates the process of replication. The virus is encapsulated into a vesicle inside the host cell, which creates a fusion of the virus and vesicle membranes. The viral ribonucleocapsid is then released into the cytoplasm of the host cell. The RNA-dependent, RNA-polymerase brought along with the virus initially binds to a promoter and begins transcription from negative-stranded to a positive-stranded mRNA. The formation of a strong hairpin sequence at the end of each gene terminates transcription. The mRNA strands are capped by the RNA-dependent, RNA-polymerase in the cytoplasm and are then subsequently translated into the four proteins essential for LCMV assembly. The ribonucleocapsid interacts with the Z matrix protein and buds on the cell membrane, releasing the virion to exit the infected cell.

In a paper published in the April 25, 2016, online edition of the journal Nature Structural & Molecular Biology, investigators at The Scripps Research Institute (La Jolla, CA, USA) described results of a long-term X-ray crystallography study that elucidated the crystal structure of the fully glycosylated prefusion GP1-GP2 complex of LCMV at a resolution of .35 nm.

The "double dimer" structure that was obtained revealed the conformational changes that the arenavirus glycoprotein must undergo to cause fusion and illustrated the fusion regions and potential oligomeric states.

"LCMV has been a beacon that has illuminated immunology and virology for decades," said senior author Dr. Erica Ollmann Saphire, professor of immunology and microbial science at The Scripps Research Institute. "This structure provides the missing roadmap to understand how to defend against its extremely lethal cousin, Lassa virus. It has moving parts. LCMV now looks like it sits between class I and class II viruses, making this structure a possible "fossil" of an intermediate evolutionary process."

Related Links:
The Scripps Research Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.